Achillion Pharmaceuticals (ACHN) Gets Wiped Out After FDA Maintains Hold On Its Lead Drug
October 15, 2013 at 10:02 AM EDT
Shares of Achillion Pharmaceuticals (ACHN) crashed 60% last week, after the company stated that the FDA maintained its clinical hold on its leading hepatitis C (HCV) drug, sovaprevir, which has been on hold for more than three months due to fears that it could cause liver damage. That news devastated shareholders, who had hoped that Read the full article... Read the rest of Achillion Pharmaceuticals (ACHN) Gets Wiped Out After FDA Maintains Hold On Its Lead Drug at InvestorGuide.com .
